These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16678891)

  • 1. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
    Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
    Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
    Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Simon R; Spichtin H; Maurer R; Metzger U; von Castelberg B; Bart R; Stopatschinskaya S; Köchli OR; Haas P; Mross F; Zuber M; Dietrich H; Bischoff S; Mirlacher M; Sauter G; Gastl G
    Breast Cancer Res Treat; 2004 Aug; 86(3):207-13. PubMed ID: 15567937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
    Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
    J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ep-CAM overexpression in breast cancer as a predictor of survival.
    Gastl G; Spizzo G; Obrist P; Dünser M; Mikuz G
    Lancet; 2000 Dec; 356(9246):1981-2. PubMed ID: 11130529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
    Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
    Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
    Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
    Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
    Aldovini D; Demichelis F; Doglioni C; Di Vizio D; Galligioni E; Brugnara S; Zeni B; Griso C; Pegoraro C; Zannoni M; Gariboldi M; Balladore E; Mezzanzanica D; Canevari S; Barbareschi M
    Int J Cancer; 2006 Oct; 119(8):1920-6. PubMed ID: 16804906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
    Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
    Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
    Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
    BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
    Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
    Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.
    Shim HS; Yoon BS; Cho NH
    Hum Pathol; 2009 May; 40(5):693-8. PubMed ID: 19157508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
    Joo M; Kim H; Kim MK; Yu HJ; Kim JP
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
    Went P; Vasei M; Bubendorf L; Terracciano L; Tornillo L; Riede U; Kononen J; Simon R; Sauter G; Baeuerle PA
    Br J Cancer; 2006 Jan; 94(1):128-35. PubMed ID: 16404366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer.
    Woopen H; Pietzner K; Richter R; Fotopoulou C; Joens T; Braicu EI; Mellstedt H; Mahner S; Lindhofer H; Darb-Esfahani S; Denkert C; Sehouli J
    J Gynecol Oncol; 2014 Jul; 25(3):221-8. PubMed ID: 25045435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.
    Kim JH; Herlyn D; Wong KK; Park DC; Schorge JO; Lu KH; Skates SJ; Cramer DW; Berkowitz RS; Mok SC
    Clin Cancer Res; 2003 Oct; 9(13):4782-91. PubMed ID: 14581349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.